Lataa...
Exenatide once-weekly injection for the treatment of type 2 diabetes in Chinese patients: current perspectives
Glucagon-like peptide-1 (GLP-1) analogs, such as exenatide, have played an important role as antidiabetic medications in the treatment of type 2 diabetes (T2DM). Like most other hypoglycemic agents, exenatide has a number of actions, including lowering blood glucose, promoting weight loss, improving...
Tallennettuna:
| Julkaisussa: | Ther Clin Risk Manag |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4539087/ https://ncbi.nlm.nih.gov/pubmed/26309403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S81088 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|